CREB1 and depressive symptom measurement: SSA has been shown to not only ameliorate depression-like behavior following cerebral ischemia through the cAMP-response element binding protein (CREB)/BDNF pathway and inhibit apoptosis of hippocampal neurons [35], but also alleviate perimenopausal depression-like symptoms.